Table 2 Demographic and clinical characteristics of study groups (AR-NAR)
From: Can nasal nitric oxide be a biomarker to differentiate allergic and non-allergic rhinitis?
Variables | AR (n, 337) | NAR (n, 106) | P value |
|---|---|---|---|
Gender, n (%) | |||
F | 197 (58.5) | 80 (75.5) | 0.002* |
M | 140 (41.5) | 26 (24.5) | |
Age, years | 25 (20-33) | 28 (22-39) | 0.004# |
BMI (kg/m2) | 23.7 ± 4.3 | 24.1 ± 4.3 | 0.466 |
BMI ≥ 25, n (%) | 111 (32.9) | 39 (36.8) | 0.465* |
BMI < 25, n (%) | 226 (67.1) | 67 (63.2) | |
Smoker, n (%) | 7 (2.1) | 3 (2.8) | 0.099* |
Non-smoker | 283 (84.7) | 97 (91.5) | |
Ex-smoker | 44 (13.2) | 6 (5.7) | |
W asthma | 48 (14.4) | 13 (12.3) | 0.789* |
TNSS | 6.7 ± 2.98 | 5.3 ± 2.57 | < 0.001 |
Rhinitis duration (year) | 5 (2-9) | 3 (2-10) | 0.037# |
Severity of rhinitis, n (%) | |||
Mild | 126 (37.4) | 64 (60.4) | < 0.001* |
Moderate-severe | 211 (62.6) | 42 (39.6) | |
W sinusitis | 146 (43.3) | 48 (45.3) | 0.723* |
Rhinitis characteristic | |||
Persistent | 99 (29.4) | 84 (79.2) | < 0.001* |
Intermittent | 217 (64.4) | 15 (14.2) | |
Persisten+Intermittent | 21 (6.2) | 7 (6.6) | |
Sensitization | |||
Monosensitization | 265 (78.6) | - | |
Polisensitization | 72 (21.4) | - | |